
    
      This research study is a Phase II clinical trial. Phase II clinical trials test the safety
      and effectiveness of an investigational drug to learn whether the drug works in treating a
      specific disease. "Investigational" means that the drug is being studied.

      The FDA (the U.S. Food and Drug Administration) has not approved Pembrolizumab for the
      participant specific disease but it has been approved for other uses.

      Pembrolizumab, also known as KEYTRUDA or MK-3475, is approved in the USA and several other
      countries to treat other types of diseases.

      The goal of this research study is to

      -Evaluate the safety and efficacy of pembrolizumab in participants with advanced esophageal
      cancer that have not responded to standard treatment.
    
  